Sec Form 13G Filing - Rush Ryan Bradford filing for ADVERUM BIOTECHNOLOGIES INC CO (ADVM) - 2024-12-17

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
SCHEDULE 13G 0002048956 XXXXXXXX LIVE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 12/17/2024 0001501756 Adverum Biotechnologies, Inc. 00773U207 100 CARDINAL WAY REDWOOD CITY CA 94063 Rush Ryan Bradford TX 1050000.00 1050000.00 1050000.00 1050000.00 1050000.00 5.1 IN Adverum Biotechnologies, Inc. 100 CARDINAL WAY, REDWOOD CITY, CALIFORNIA, 94063 Ryan Bradford Rush, MD 8201 Valcour Drive, Amarillo, TX 79119 USA Y 1,050,000 5.1 1,050,000 1,050,000 1,050,000 1,050,000 Y N Y Y Y Y Y Rush Ryan Bradford Rush Ryan Bradford 12/17/2024